Aptose Biosciences Inc (APTO) concluded trading on Thursday at a closing price of $0.17, with 28.71 million shares of worth about $4.88 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -77.61% during that period and on December 19, 2024 the price saw a loss of about -4.81%. Currently the company’s common shares owned by public are about 59.52M shares, out of which, 55.85M shares are available for trading.
Stock saw a price change of -11.58% in past 5 days and over the past one month there was a price change of -52.62%. Year-to-date (YTD), APTO shares are showing a performance of -93.30% which decreased to -92.79% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.13 but also hit the highest price of $2.68 during that period. The average intraday trading volume for Aptose Biosciences Inc shares is 493.61K. The stock is currently trading -10.23% below its 20-day simple moving average (SMA20), while that difference is down -43.49% for SMA50 and it goes to -76.70% lower than SMA200.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Aptose Biosciences Inc (NASDAQ: APTO) currently have 59.52M outstanding shares and institutions hold larger chunk of about 5.43% of that.
The stock has a current market capitalization of $10.13M and its 3Y-monthly beta is at 0.92. It has posted earnings per share of -$3.05 in the same period. It has Quick Ratio of 1.05. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for APTO, volatility over the week remained 7.22% while standing at 12.89% over the month.
Stock’s fiscal year EPS is expected to rise by 76.39%.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Cantor Fitzgerald on October 19, 2020 offering an Overweight rating for the stock and assigned a target price of $10 to it. Coverage by Alliance Global Partners stated Aptose Biosciences Inc (APTO) stock as a Buy in their note to investors on September 22, 2020, suggesting a price target of $12 for the stock. On February 20, 2020, Maxim Group Initiated their recommendations, while on February 06, 2020, H.C. Wainwright Reiterated their ratings for the stock with a price target of $9. Stock get an Overweight rating from Piper Sandler on January 09, 2020.
